Approval · Notice of Compliance 3744 · 1997
POSIJECT: Notice of Compliance 3744
Issued April 9, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3744
- Date
- April 9, 1997
- Company
- Leiras OyTampere, Saone Et Loire, Finland
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Inotropic agent
- Canadian reference product
- DOBUTREX (Eli Lilly And Company)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POSIJECT | 02231084 | — |
Medicinal ingredients
- DOBUTAMINE HCL 50 MG per ML